News in Brief
Health - Jun 5
No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
Health - Jun 5
New resources on talking to children about illness and death during the COVID-19 pandemic | University of Oxford
New resources on talking to children about illness and death during the COVID-19 pandemic | University of Oxford
Environment - Jun 5
Reveals Bristol won’t reach 2030 carbon neural target without major transport transformation
Reveals Bristol won’t reach 2030 carbon neural target without major transport transformation
science wire
« BACK
Pharmacology - 19.02.2020
Health - Pharmacology - 18.02.2020
Pharmacology - Health - 17.02.2020
Pharmacology - Health - 17.02.2020
Pharmacology - Health - 17.02.2020
Pharmacology - Health - 13.02.2020 
Instant prescriptions: we need to manage the risks
Instant prescriptions might be the way of our digital future, but we need to manage the risks first, write academics from our Faculty of Medicine and Health.
Health - Pharmacology - 13.02.2020
Pharmacology - Health - 12.02.2020
Health - Pharmacology - 12.02.2020
Pharmacology - Health - 11.02.2020
Pharmacology - Health - 11.02.2020
Health - Pharmacology - 11.02.2020
Pharmacology - Life Sciences - 10.02.2020
Pharmacology - 07.02.2020
Health - Pharmacology - 05.02.2020
Health - Pharmacology - 02.02.2020 
Singing for joy and service
After surgery to correct childhood hearing loss, Swarna Jeewajee discovered a a desire to be a physician-scientist, and a love of a cappella music.
Pharmacology - Health - 31.01.2020
Pharmacology - Economics / Business - 31.01.2020
Health - Pharmacology - 30.01.2020
Pharmacology - Health - 30.01.2020
Health - Pharmacology - 30.01.2020
Pharmacology - Health - 29.01.2020 
& Development for Parasitic Worm Infections Lags Behind
Neglected tropical diseases (NTDs) are a group of mainly chronic infectious diseases that affect more than a billion people in tropical and subtropical countries.
Pharmacology - Economics / Business - 29.01.2020
Health - Pharmacology - 28.01.2020 
The universities of Bern and Zurich offer continuing education in gender-specific medicine
There is increasing evidence that health behavior and disease manifestation differ substantially between women and men.
Pedagogy - Pharmacology - 28.01.2020
Life Sciences - Pharmacology - 28.01.2020 
More than a knee injury: ACL tears cause harmful changes in our brain structure
It's known that some joint function is often permanently lost after anterior cruciate ligament reconstruction, and re-injury is common even with intensive physical therapy, but it's unclear why. New research from the University of Michigan School of Kinesiology shows structural changes in the brains of patients who underwent ACL reconstruction.
Health - Pharmacology - 27.01.2020
Pharmacology - Health - 27.01.2020
Pharmacology - Life Sciences - 24.01.2020
Pharmacology - Life Sciences - 24.01.2020
Pharmacology - Life Sciences - 23.01.2020
Health - Pharmacology - 23.01.2020
Pharmacology - Health - 23.01.2020
Pharmacology - Innovation - 22.01.2020
Pharmacology - 22.01.2020
Health - Pharmacology - 22.01.2020 
Antiviral treatments inspire new kind of cancer drug
An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice. Stanford virologist Jeffrey Glenn did not set out to tackle cancer. For years, he and his lab have worked to develop new ways of battling viruses like the ones that cause hepatitis delta and the common cold - but the lessons they've learned fighting viruses has led to a new kind of drug that has been effective at treating cancer in mice.
Pharmacology - 22.01.2020
Pharmacology - Health - 21.01.2020 
American dreams come true for Fulbright scholars
University of Queensland scientists are heading ‘stateside' with the support of 2020 Fulbright scholarships.
Pharmacology - Health - 21.01.2020
Pharmacology - Health - 20.01.2020
Pharmacology - Health - 15.01.2020
Pharmacology - Health - 15.01.2020
Health - Pharmacology - 15.01.2020
Health - Pharmacology - 15.01.2020
Health - Pharmacology - 14.01.2020
Pharmacology - Health - 14.01.2020
Pharmacology - Health - 13.01.2020
Pharmacology - Health - 10.01.2020 
New partnership with international pharmaceutical company provides up to $10 million for drug development research at U-M
The University of Michigan and Sun Pharma Advanced Research Company have launched a partnership to accelerate the development of potential new medicines for a wide range of diseases. The new venture will provide up to a total of $10 million in financial support and in-kind industry resources to move various promising drug-discovery research projects within the university toward the ultimate goal of new therapies for patients.
Health - Pharmacology - 10.01.2020
Health - Pharmacology - 09.01.2020 
First patient for Parkinson’s disease trial recruited
The trial, funded by a £2.1 million grant from the National Institute for Health Research (NIHR) , will test whether a commonly prescribed dementia drug could prevent debilitating falls for people with the disease.
Pharmacology
Results 201 - 250 of 1819.
Talking back pain with U of M
Back pain is the leading cause of disability worldwide and an estimated 80% of the population will experience back pain at some time in their lives, according to the American Chiropractic Association.
Back pain is the leading cause of disability worldwide and an estimated 80% of the population will experience back pain at some time in their lives, according to the American Chiropractic Association.
Instant prescriptions might be the way of our digital future, but we need to manage the risks first, write academics from our Faculty of Medicine and Health.
GPs and pharmacists need to develop trusting relationships
The research, published in the British Journal of General Practice today [11 February], asked GPs and pharmacists about their views on what helps and what hinders them from working together to make the best use of medicines for patients with multiple health problems. The study found that 'knowing each other' and a good working relationship were key to working together well.
The research, published in the British Journal of General Practice today [11 February], asked GPs and pharmacists about their views on what helps and what hinders them from working together to make the best use of medicines for patients with multiple health problems. The study found that 'knowing each other' and a good working relationship were key to working together well.
Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review
Patients & Caregivers Healthcare Professionals Society & ESG FDA Priority Review for capmatinib based on Phase II data in first-line and previously treated patients with MET exon 14 skipping
Patients & Caregivers Healthcare Professionals Society & ESG FDA Priority Review for capmatinib based on Phase II data in first-line and previously treated patients with MET exon 14 skipping
Talking cancer prevention with U of M
February is National Cancer Prevention Month. In Minnesota, there are an estimated 142,369 new cancer cases every year. Professor Timothy Church with the University of Minnesota answers questions on lifestyle changes people can make to reduce their risk of getting cancer.
February is National Cancer Prevention Month. In Minnesota, there are an estimated 142,369 new cancer cases every year. Professor Timothy Church with the University of Minnesota answers questions on lifestyle changes people can make to reduce their risk of getting cancer.
Countering therapy resistance in colorectal cancer - News
A new treatment modality for colorectal cancers that do not respond to standard chemotherapy has been identified by Tatiana Petrova of the Lausanne Branch of the Ludwig Institute for Cancer Research and Michele De Palma of the EPFL. Colorectal cancer (CRC) is one of the leading causes of cancer-related mortality.
A new treatment modality for colorectal cancers that do not respond to standard chemotherapy has been identified by Tatiana Petrova of the Lausanne Branch of the Ludwig Institute for Cancer Research and Michele De Palma of the EPFL. Colorectal cancer (CRC) is one of the leading causes of cancer-related mortality.
After surgery to correct childhood hearing loss, Swarna Jeewajee discovered a a desire to be a physician-scientist, and a love of a cappella music.
Heart surgeon dedicates career to helping patients no one else can save
Nearly three decades ago, Valluvan Jeevanandam was six months into his first job as a heart surgeon when a critically ill patient pleaded with him: Get me a transplant today, or I am going to die.
Nearly three decades ago, Valluvan Jeevanandam was six months into his first job as a heart surgeon when a critically ill patient pleaded with him: Get me a transplant today, or I am going to die.
Mothers on antiepileptic medication can safely breastfeed
Breastfeeding is associated with benefits for children and their mothers. However, when mothers take medications there is a potential for adverse side effects in the infant.
Breastfeeding is associated with benefits for children and their mothers. However, when mothers take medications there is a potential for adverse side effects in the infant.
U.S. rural breast cancer patients must routinely travel long distances for treatment
The closing of rural hospitals and specialty care units is causing many people, including breast cancer patients, to seek treatment far from home.
The closing of rural hospitals and specialty care units is causing many people, including breast cancer patients, to seek treatment far from home.
Neglected tropical diseases (NTDs) are a group of mainly chronic infectious diseases that affect more than a billion people in tropical and subtropical countries.
There is increasing evidence that health behavior and disease manifestation differ substantially between women and men.
The Daily Mile(TM) programme can be part of schools’ work on childhood obesity prevention
A study evaluating the effectiveness of the widely used ‘Daily Mile' intervention in schools to tackle childhood obesity has found that the benefits are small, and may be greater in girls than boys.
A study evaluating the effectiveness of the widely used ‘Daily Mile' intervention in schools to tackle childhood obesity has found that the benefits are small, and may be greater in girls than boys.
It's known that some joint function is often permanently lost after anterior cruciate ligament reconstruction, and re-injury is common even with intensive physical therapy, but it's unclear why. New research from the University of Michigan School of Kinesiology shows structural changes in the brains of patients who underwent ACL reconstruction.
Six patients with rare blood disease are doing well after gene therapy clinical trial
UCLA researchers are part of an international team that reported the use of a stem cell gene therapy to treat nine people with the rare, inherited blood disease known as X-linked chronic granulomatous disease, or X-CGD.
UCLA researchers are part of an international team that reported the use of a stem cell gene therapy to treat nine people with the rare, inherited blood disease known as X-linked chronic granulomatous disease, or X-CGD.
Roche submits supplemental Biologics License Application to the FDA for Tecentriq in combination with Avastin for the most common form of liver cancer
Application is being reviewed under FDA's Real-Time Oncology Review pilot programme Roche today announced the completion of a supplemental Biologics License Application (sBLA) submission to the US Fo
Application is being reviewed under FDA's Real-Time Oncology Review pilot programme Roche today announced the completion of a supplemental Biologics License Application (sBLA) submission to the US Fo
UQ responds to coronavirus outbreak
The University of Queensland has been asked to develop a vaccine for the recent coronavirus outbreak at unprecedented speed, using new technology.
The University of Queensland has been asked to develop a vaccine for the recent coronavirus outbreak at unprecedented speed, using new technology.
’A Tornado at the Front Door, a Tsunami at the Back Door’
20-year-old born with rare disease arrives at crossroads: continue toward future most likely leading to early death or become first patient to undergo new gene-and-stem cell therapy developed by Scho
20-year-old born with rare disease arrives at crossroads: continue toward future most likely leading to early death or become first patient to undergo new gene-and-stem cell therapy developed by Scho
Q&A: Coronavirus outbreak and health policy implications
The outbreak of a novel coronavirus that began in December 2019 in Wuhan, China "is evolving and complex," said the head of the World Health Organization (WHO) after its emergency committee convened
The outbreak of a novel coronavirus that began in December 2019 in Wuhan, China "is evolving and complex," said the head of the World Health Organization (WHO) after its emergency committee convened
Launch of Bristol: Take Drugs Seriously
A series of ground-breaking events that aim to change the way we talk about drug use, policy and harm reduction launches in Bristol tomorrow [Thursday 23 January].
A series of ground-breaking events that aim to change the way we talk about drug use, policy and harm reduction launches in Bristol tomorrow [Thursday 23 January].
An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice. Stanford virologist Jeffrey Glenn did not set out to tackle cancer. For years, he and his lab have worked to develop new ways of battling viruses like the ones that cause hepatitis delta and the common cold - but the lessons they've learned fighting viruses has led to a new kind of drug that has been effective at treating cancer in mice.
University of Queensland scientists are heading ‘stateside' with the support of 2020 Fulbright scholarships.
European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma
Novel combination regimen includes first-in-class antibody-drug conjugate that specifically targets CD79b Targeted off-the-shelf treatment provides much-needed new option for people with relapsed or
Novel combination regimen includes first-in-class antibody-drug conjugate that specifically targets CD79b Targeted off-the-shelf treatment provides much-needed new option for people with relapsed or
Novartis announces EU approval of Mayzent (siponimod) for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease
Patients & Caregivers Healthcare Professionals Society & ESG Mayzent (siponimod) is the first and only oral treatment specifically indicated for patients with secondary progressive multiple s
Patients & Caregivers Healthcare Professionals Society & ESG Mayzent (siponimod) is the first and only oral treatment specifically indicated for patients with secondary progressive multiple s
We must be smarter about how we use antibiotics, says Imperial researcher
Not enough focus is being paid to using antibiotics more appropriately to minimise the threat of drug-resistant bugs, said an expert in a recent talk. Alison Holmes, Professor of Infectious Diseases at Imperial College London and Director of Infection Prevention and Control at Imperial College Healthcare NHS Trust, is leading a newly created centre to tackle drug-resistant infections.
Not enough focus is being paid to using antibiotics more appropriately to minimise the threat of drug-resistant bugs, said an expert in a recent talk. Alison Holmes, Professor of Infectious Diseases at Imperial College London and Director of Infection Prevention and Control at Imperial College Healthcare NHS Trust, is leading a newly created centre to tackle drug-resistant infections.
Involving family in care for bipolar disorder helps children and teens stay healthier, longer
In a UCLA-led study, children and adolescents with a high risk for developing bipolar disorder stayed healthier for longer periods when their family members participated in their psychotherapy sessions.
In a UCLA-led study, children and adolescents with a high risk for developing bipolar disorder stayed healthier for longer periods when their family members participated in their psychotherapy sessions.
Drug resistance is "up there with climate change" as a global threat
The threat posed by drug resistant infections should be taken as seriously as climate change, says an Imperial expert.
The threat posed by drug resistant infections should be taken as seriously as climate change, says an Imperial expert.
Genome editing at the crossroads of scandal and cure
Genetic modification of babies in China one year ago was universally condemned. At the same time, CRISPR treatments are on their way into our clinics.
Genetic modification of babies in China one year ago was universally condemned. At the same time, CRISPR treatments are on their way into our clinics.
New heart disease drug to be made available to NHS patients through ground-breaking collaboration
Up to 30,000 lives could be saved over the next decade thanks to a proposed pioneering government collaboration with pharmaceutical company Novartis to tackle heart disease - a leading cause of death in the UK.
Up to 30,000 lives could be saved over the next decade thanks to a proposed pioneering government collaboration with pharmaceutical company Novartis to tackle heart disease - a leading cause of death in the UK.
Project aims to improve diagnosis and treatment for patients with anaemia
Ambulatory care specialists at the University of Birmingham, with support from Vifor Pharma UK Limited (VPUK), are working to develop and implement a population based anaemia diagnosis and treatment decision support service for routine healthcare delivery.
Ambulatory care specialists at the University of Birmingham, with support from Vifor Pharma UK Limited (VPUK), are working to develop and implement a population based anaemia diagnosis and treatment decision support service for routine healthcare delivery.
The University of Michigan and Sun Pharma Advanced Research Company have launched a partnership to accelerate the development of potential new medicines for a wide range of diseases. The new venture will provide up to a total of $10 million in financial support and in-kind industry resources to move various promising drug-discovery research projects within the university toward the ultimate goal of new therapies for patients.
Cancer researchers call for ambitious survival targets for the 2020s
The NHS should raise their five-year lung cancer survival targets to 35% by 2030, concludes a new 'state of the nation' policy report conducted by UCL.
The NHS should raise their five-year lung cancer survival targets to 35% by 2030, concludes a new 'state of the nation' policy report conducted by UCL.
The trial, funded by a £2.1 million grant from the National Institute for Health Research (NIHR) , will test whether a commonly prescribed dementia drug could prevent debilitating falls for people with the disease.
News in Brief
Health - Jun 5
No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
Health - Jun 5
New resources on talking to children about illness and death during the COVID-19 pandemic | University of Oxford
New resources on talking to children about illness and death during the COVID-19 pandemic | University of Oxford
Environment - Jun 5
Reveals Bristol won’t reach 2030 carbon neural target without major transport transformation
Reveals Bristol won’t reach 2030 carbon neural target without major transport transformation